‘Never too late’ for senior living providers to help residents reduce Alzheimer’s risk: report
By
Kimberly Bonvissuto
Oct 18, 2023
It’s “never too early, never too late” for senior living providers to help residents reduce their risk for developing Alzheimer’s disease, suggests the World Alzheimer Report 2023.
Memory care ‘buddies’ will build connections between residents, college students
By
Kimberly Bonvissuto
Oct 13, 2023
A “buddy” program connecting pre-med college students with memory care residents will create connections, promote careers in gerontology, combat ageism and improve the quality of life for residents,...
Act prioritizes fight against Alzheimer’s disease with state plan
By
Kimberly Bonvissuto
Sep 12, 2023
South Carolina’s adoption of a state Alzheimer’s plan is a “step forward,” according to senior living advocates.
CMS dementia care pilot program to expand care delivery options
By
Kimberly Bonvissuto
Aug 01, 2023
Assisted living residents may be part of a new Medicare dementia care model that will test an alternative payment for family caregivers while expanding care delivery options to allow people living with...
Finger prick, venous blood can ID key Alzheimer’s disease biomarkers
Jul 20, 2023
Capillary and venous dry blood spot can identify glial fibrillary acidic protein, neurofilament light and phosphorylated tau.
FDA gives full approval to Alzheimer’s disease drug Leqembi
Jul 06, 2023
Although Leqembi did help reduce mental decline compared with placebo, the drug has been linked to two deaths from brain bleeds.
Package of bills targets memory care services, staffing agency regulation
By
Kimberly Bonvissuto
Jun 06, 2023
Delaware lawmakers took the recommendations from a recently released long-term care task force report to heart in introducing a package of bills that target dementia care and temporary staffing agency...
Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
May 17, 2023
Genetically determined high-density lipoprotein cholesterol and systolic blood pressure were linked to increased odds of Alzheimer’s disease.
FDA approves first drug meant to ease Alzheimer’s disease-llnked agitation
May 11, 2023
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
$215,000 disability discrimination complaint could have ‘broader ramifications’ on resident contracts,...
By
Kimberly Bonvissuto
Apr 12, 2023
A Pennsylvania continuing care retirement community agreed to a $215,000 Fair Housing Act settlement over allegations of disability discrimination, but the senior living owners and operators said that...